Ken Fisher's DNTH Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 12,620 shares of Dianthus Therapeutics, Inc. (DNTH) worth $1.06 M, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Ken Fisher has initiated a new position in DNTH, representing a fresh investment thesis on this company. Largest reduction occurred in Q1 2026, reducing 1,328 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Dianthus Therapeutics (DNTH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Dianthus Therapeutics (DNTH) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1,328 | Reduce 9.52% | 12,620 | $83.92 |
| Q4 2025 | +13,948 | New Buy | 13,948 | $41.21 |
Ken Fisher's Dianthus Therapeutics Investment FAQs
Ken Fisher first purchased Dianthus Therapeutics, Inc. (DNTH) in Q4 2025, acquiring 13,948 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Dianthus Therapeutics, Inc. (DNTH) for 2 quarters since Q4 2025.
Ken Fisher's largest addition to Dianthus Therapeutics, Inc. (DNTH) was in Q4 2025, adding 13,948 shares worth $574,797.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 12,620 shares of Dianthus Therapeutics, Inc. (DNTH), valued at approximately $1.06 M.
As of the Q1 2026 filing, Dianthus Therapeutics, Inc. (DNTH) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Dianthus Therapeutics, Inc. (DNTH) was 13,948 shares, as reported at the end of Q4 2025.